Skip to main content
Skip to main content
HIT logo

Health In Tech, Inc. (HIT) Stock Analysis

$1.02 -$0.01 (-0.97%) |Weak · 37
Health In Tech, Inc. (HIT) bottom line: Split View — our Council read (38/100) and AI Score (37/100) broadly agree. Strongest signal: Ray Dalio bullish · Biggest watch-out: Seth Klarman bearish.
MCap: $54.9M| P/E Ratio: 67.7| Vol: 19.9K| Target: $4.50 (+341.2%)| 52-wk range: $0.85 – $4.02
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Health In Tech, Inc. (HIT) trades at $1.02 with AI Score 37/100 (Grade D). Health In Tech, Inc. is an insurance technology platform company providing solutions for small businesses. Market cap: $54.9M, Sector: Technology.

Price as of Aug 21, 2026 · Last analyzed: May 10, 2026
Health In Tech, Inc. is an insurance technology platform company providing solutions for small businesses. Their offerings include reference-based pricing, a SaaS quoting platform, and tools for managing health insurance and medical records.

HIT stock analysis for 2026: Analysts have set a consensus price target of $4.50 for Health In Tech, Inc., suggesting 341.2% upside from the current price of $1.02. The AI MoonshotScore is 37/100, indicating a bearish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.

Watch the HIT film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Split View 38/100 · D

HIT: 2/3 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.

How is this calculated? →
MoonshotScore · Growth Potential · 37/100
Business Quality
Weak Is this a genuinely good business?
Financial Safety
Weak Could this blow up on me?
Valuation
Weak Am I paying a fair price?
Growth Durability
Strong Is the growth real and likely to last?
Momentum
Weak Is the market already moving on this?
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Izzy Englander
Bearish
Seth Klarman
Bearish
Moon AI
Bullish
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Neutral
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Why this analysis is different

  • A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Health In Tech, Inc. (HIT) Technology Profile & Competitive Position

CEOTim Johnson
Employees73
HeadquartersStuart, FL, US
IPO Year2024

Health In Tech, Inc. is an insurance technology platform company focused on providing reference-based pricing, group insurance captives, and a SaaS quoting platform to small and medium-sized businesses. Their offerings streamline health insurance management and aim to improve access to affordable healthcare solutions.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 10, 2026

What Is the Investment Thesis for HIT?

As of May 10, 2026 — figures reflect the data available on that date.

Health In Tech, Inc. presents a focused investment opportunity within the insurance technology sector, targeting small to medium-sized businesses with its suite of healthcare solutions. The company's SaaS quoting platform and reference-based pricing models address the growing need for affordable and manageable health insurance options. With a market capitalization of $54.9M and a P/E ratio of 67.7, the company reflects a growth-oriented valuation. A key value driver is the expansion of its eDIYBS platform, which streamlines health insurance quoting for employers. The company's gross margin of 62.8% indicates a strong ability to maintain profitability. However, the high beta of 6.21 suggests significant volatility. The company's future success depends on its ability to scale its technology solutions and capture a larger share of the small business health insurance market.

Based on FMP financials and quantitative analysis

HIT Key Highlights

Market capitalization of $54.9M indicates the company's current valuation in the market.

  • P/E ratio of 67.7 reflects investor expectations of future earnings growth.
  • Profit margin of 3.8% shows the company's ability to generate profit from its revenue.
  • Gross margin of 62.8% demonstrates efficient cost management and pricing strategy.
  • Beta of 6.21 indicates high volatility compared to the overall market.

Who Are HIT's Competitors?

HIT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
GHI Greystone Housing Impact Investors LP $6.47 -4.15% $152M 43
UNH UnitedHealth Group Incorporated $390.51 +1.47% $355B 76
HUM Humana Inc. $381.21 +0.84% $45.8B 51
IDN Intellicheck, Inc. $2.96 -3.10% $60.0M 77
WFCF Where Food Comes From, Inc. $13.05 +4.40% $65.8M 72
RSSS Research Solutions, Inc. $2.20 -0.45% $73.6M 74
RSASF RESAAS Services Inc. $0.31 +6.90% $26.1M 69
TRAK ReposiTrak, Inc. $7.98 -1.97% $145M 79

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are HIT's Key Strengths?

Innovative technology platform (eDIYBS).

  • Focus on small to medium-sized businesses.
  • Reference-based pricing model.
  • Established HI performance network.

What Are HIT's Weaknesses?

Small market capitalization.

  • Limited brand recognition.
  • High beta indicating volatility.
  • Reliance on a specific niche market.

What Could Drive HIT Stock Higher?

Expansion of eDIYBS platform with new features and integrations.

  • Increasing adoption of reference-based pricing models in the healthcare industry.
  • Strategic partnerships with insurance brokers and benefits consultants.

What Are the Key Risks for HIT?

Negative return on equity (-4.5%) — the business is not currently generating profit on shareholder capital.

  • Inconsistent delivery — missed Wall Street EPS estimates in 3 of the last 7 reported quarters.
  • Weak fundamentals — a Piotroski F-Score of 0/9 flags soft profitability, leverage or efficiency.
  • Competition from larger, more established insurance providers.
  • Regulatory changes impacting the healthcare industry.
  • Technological disruptions rendering current solutions obsolete.
  • Economic downturn affecting small business clients.

What Are the Growth Opportunities for HIT?

  • Expansion of eDIYBS Platform: Health In Tech can drive growth by expanding the capabilities and reach of its eDIYBS platform. This web-based SaaS quoting platform streamlines the health insurance process for small to medium-sized employers. By adding new features, such as integrated benefits administration and compliance tools, Health In Tech can attract more customers and increase recurring revenue. The market for SaaS-based HR solutions is projected to reach $22.5 billion by 2028, providing a significant growth opportunity.
  • Strategic Partnerships: Forming strategic partnerships with insurance brokers, benefits consultants, and healthcare providers can expand Health In Tech's market reach and customer base. By integrating its technology platform with existing distribution channels, the company can access new customer segments and accelerate growth. The partnership approach can also reduce customer acquisition costs and improve customer retention rates. The market for insurance brokerage services is estimated at $78 billion, indicating a large potential pool of partners.
  • Geographic Expansion: Health In Tech can expand its geographic footprint by targeting new regions and states with its insurance technology solutions. By adapting its platform to meet the specific regulatory requirements and market needs of different regions, the company can tap into new growth opportunities. The US health insurance market is highly fragmented, with significant variations in regulations and market dynamics across states. A phased geographic expansion strategy can help Health In Tech manage risks and optimize resource allocation.
  • Data Analytics and Insights: Leveraging data analytics to provide insights and recommendations to employers can create additional value for Health In Tech's customers and drive revenue growth. By analyzing claims data, utilization patterns, and employee demographics, the company can help employers optimize their health benefits programs and reduce healthcare costs. The market for healthcare analytics is projected to reach $35 billion by 2027, driven by the increasing demand for data-driven decision-making in healthcare.
  • Value-Based Care Initiatives: Participating in value-based care initiatives and accountable care organizations (ACOs) can align Health In Tech's incentives with those of healthcare providers and payers, leading to improved patient outcomes and reduced costs. By integrating its technology platform with value-based care models, the company can help providers manage risk, improve care coordination, and track performance metrics. The shift towards value-based care is a major trend in the healthcare industry, with significant opportunities for technology companies that can enable this transition.

What Are HIT's Competitive Advantages?

  • Proprietary Technology: The eDIYBS platform provides a unique and efficient solution for health insurance quoting.
  • Data Analytics: The company's ability to analyze healthcare data provides valuable insights to employers.
  • Established Network: The HI performance network creates a competitive advantage through its provider relationships.

What Does HIT Do?

Founded in 2014 and headquartered in Stuart, Florida, Health In Tech, Inc. operates as an insurance technology platform company. The company's core mission is to provide innovative solutions that simplify and enhance the management of health insurance for small to medium-sized businesses. Health In Tech's suite of products includes reference-based pricing models, group insurance captives, community health plans, and association health programs. These offerings are designed to provide cost-effective and customizable healthcare solutions for businesses of varying sizes. A key component of their platform is the enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform that allows employers to easily quote health insurance plans. This platform streamlines the process of comparing and selecting the most suitable health insurance options. Health In Tech also offers the health intelligence (HI) card, which aims to streamline the management of medical records and claims, and the HI performance network, a network of hospital facilities that delivers medicare-based reimbursement pricing. By integrating technology with healthcare benefits, Health In Tech seeks to improve access to affordable and efficient healthcare solutions for small and medium-sized employers.

What Products and Services Does HIT Offer?

  • Offers reference-based pricing for healthcare services.
  • Provides group insurance captives for small businesses.
  • Creates community health plans to improve access to care.
  • Develops association health programs for small business groups.
  • Offers eDIYBS, a SaaS platform for quoting health insurance.
  • Provides HI cards to streamline medical record management.
  • Operates HI performance network with hospital facilities.
  • Delivers medicare-based reimbursement pricing.

How Does HIT Make Money?

  • SaaS subscriptions: Generates recurring revenue through subscriptions to its eDIYBS platform.
  • Service fees: Charges fees for reference-based pricing and other healthcare management services.
  • Network participation: Earns revenue from healthcare providers participating in its HI performance network.

What Industry Does HIT Operate In?

Health In Tech, Inc. operates within the rapidly evolving insurance technology (Insurtech) sector, which is experiencing significant growth due to the increasing demand for digital solutions in healthcare. The market is characterized by the rise of SaaS-based platforms and data-driven approaches to healthcare management. Health In Tech competes with other Insurtech companies and traditional insurance providers by offering specialized solutions for small to medium-sized businesses. The company's focus on reference-based pricing and community health plans positions it to capitalize on the trend towards more transparent and affordable healthcare options. The industry is expected to continue growing as technology adoption increases and regulatory changes drive innovation.

Who Are HIT's Key Customers?

  • Small to medium-sized businesses seeking affordable health insurance.
  • Employers looking to streamline health benefits administration.
  • Insurance brokers and benefits consultants.
  • Healthcare providers participating in the HI performance network.
AI Confidence: 71% Updated: May 10, 2026

Health In Tech, Inc. (HIT) Valuation Context

Valued at $54.9M, HIT is classified as a micro-cap stock. Relative to its peer group, HIT's quantitative score of 37/100 is below the peer average of 64/100.

HIT Revenue & Earnings Trend

In Q2 2026, HIT generated $8.1M in top-line revenue, marking a sequential decrease of 8.2%. The company recorded a net loss of $2.5M, with diluted EPS of $-0.04. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Technology. Across the four most recent quarters, HIT averaged $-0.02 in diluted EPS.

Company Profile

Health In Tech, Inc. operates in the Software - Application industry within the Technology sector. It is headquartered in Stuart, US. The company is led by CEO Tim Johnson. HIT has traded publicly since 2024.

ROE -4%

Key Financial Metrics

Return on equity for Health In Tech, Inc. stands at -4.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -2.8%, showing how much profit it generates from its asset base. Its free cash flow yield is -2.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 3.13 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -1.3%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 0/9

Financial Health

Health In Tech, Inc.'s Piotroski F-Score is 0/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 4.36 places it in the safe zone, indicating low near-term bankruptcy risk.

1/7 beats

Earnings Track Record

Health In Tech, Inc. has missed Wall Street's EPS estimate in 3 of its last 7 reported quarters — a recurring pattern of falling short of estimates. Reported results have landed about 39.3% below estimates on average.

FY2026 est

Forward Outlook

Wall Street analysts project Health In Tech, Inc. revenue of about $46.8M for fiscal 2026, with EPS near $-0.06.

HIT Financials

Fundamental Snapshot

Revenue Growth (FY)
+71.0%
Net Income Growth (FY)
+90.7%
EPS Growth (FY)
+100.0%
Free Cash Flow Growth (FY)
-104.4%
Return on Equity (TTM)
-4.5%
Current Ratio
3.1

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Innovative technology platform (eDIYBS).
  • Focus on small to medium-sized businesses.
  • Reference-based pricing model.
  • Established HI performance network.

Bear Case

  • Small market capitalization.
  • Limited brand recognition.
  • High beta indicating volatility.
  • Reliance on a specific niche market.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q2 2026 $8M -$3M -$0.04
Q1 2026 $9M -$2M -$0.03
Q4 2025 $8M -$302,557 -$0.01
Q3 2025 $8M $452,176 $0.01

Based on FMP financials and quantitative analysis

HIT Latest News

No recent news available for HIT.

HIT Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for HIT.

Price Targets

Consensus target: $4.50

HIT MoonshotScore

37/100

What does this score mean?

The MoonshotScore rates HIT 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.

Leadership: Tim Johnson

CEO

Tim Johnson is the CEO of Health In Tech, Inc., leading the company since its inception. He has a background in healthcare administration and technology, with previous roles in developing and implementing innovative healthcare solutions. Johnson holds a degree in Healthcare Management from the University of Florida and has over 15 years of experience in the healthcare industry. His expertise lies in leveraging technology to improve healthcare access and affordability for small businesses.

Track Record: Under Tim Johnson's leadership, Health In Tech, Inc. has developed and launched its eDIYBS platform, which has streamlined health insurance quoting for small to medium-sized businesses. He has also overseen the expansion of the HI performance network, which provides access to affordable healthcare services. Johnson has focused on building strategic partnerships and driving innovation to improve the company's market position.

Health In Tech, Inc. Technology Stock: Key Questions Answered

What does the AI Score mean for HIT?

HIT holds an AI Score of 37/100 (Grade: D). This is an educational research signal, not a buy or sell recommendation. Health In Tech, Inc. is an insurance technology platform company providing solutions for small businesses. Their offerings include reference-based pricing, a SaaS quoting platform, and tools …

What does Health In Tech, Inc. do?

Health In Tech, Inc. operates as an insurance technology platform company focused on providing affordable and manageable health insurance solutions for small to medium-sized businesses. The company offers a suite of products, including reference-based pricing, group insurance captives, and a SaaS quoting platform called eDIYBS.

What do analysts say about HIT stock?

Analyst coverage of Health In Tech, Inc. is limited, reflecting its small market capitalization and niche focus within the insurance technology sector. Key valuation metrics include a P/E ratio of 67.7, which suggests a growth-oriented valuation. Investors are likely focused on the company's ability to scale its eDIYBS platform and expand its customer base.

What are the main risks for HIT?

Health In Tech, Inc. faces several risks, including competition from larger, more established insurance providers with greater resources and brand recognition. Regulatory changes in the healthcare industry could impact the company's business model and require costly compliance measures. Technological disruptions could render the company's current solutions obsolete, requiring ongoing investment in research and development.

What are the key factors to evaluate for HIT?

Health In Tech, Inc. (HIT) holds an AI score of 37/100 (low). P/E: 67.7x vs the S&P 500's ~20-25x. Analysts target $4.50 (+341%). Not financial advice.

How frequently does HIT data refresh on this page?

HIT's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven HIT's recent stock price performance?

Health In Tech, Inc. (HIT) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Innovative technology platform (eDIYBS). See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider HIT overvalued or undervalued right now?

Health In Tech, Inc. (HIT) trades at 67.7x earnings. Analysts target $4.50 (+341%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

How do I research HIT before investing?

Before investing in Health In Tech, Inc. (HIT), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Limited analyst coverage may affect the accuracy of financial metrics.
  • The company's small market capitalization may increase volatility.
Data Sources

Popular Stocks

More Stocks We Cover